Side effects and watch-outs
- Nausea/vomiting (very common)
- Diarrhoea
- Constipation
- Headache
- Rare: pancreatitis
- Rare: gallbladder disease
- Thyroid C-cell concern
- Injection site reaction
- Heart rate increase
Peptide / Metabolic
Liraglutide (Saxenda)
FDA-approved GLP-1 agonist (Saxenda for obesity; Victoza for T2DM). Daily injection. Older generation than semaglutide but well-studied long-term cardiovascular safety.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.